NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 13-24 of 500 results.

IVTEAM

Infective endocarditis treatment with OPAT – Full Text

"OPAT appears to be safe and effective for IE patients, with low mortality and relapse rates. However, increased readmission rates and IV-line complications warrant careful patient selection and monitoring. Further prospective trials are needed to refine OPAT protocols" Ashraf et al (2025).

IVTEAM

CLABSI reduction using tissue adhesive

"To investigate whether tissue adhesive (TA, 2-octyl blended with n-butyl cyanoacrylate) application to centrally/femorally inserted central catheters (CICCs/FICCs) exit sites could reduce the occurrence of central line-associated bloodstream infection (CLABSI)” Kwon et al (2025).

IVTEAM

VIP score quality improvement project

"This QIP has successfully reduced early phlebitis rate in this patient population to 2.1%, which is now in-keeping with CDC guidance of <5%. In addition, there was a 65.5% improvement in documentation of VIP score demonstrating increased application of the tool in clinical practice” O’Donnell et al (2024).

IVTEAM

AccuVein research protocol – Full Text

"To verify the effectiveness of AccuVeinAV300® in the success of peripheral intravenous catheterization in adults with difficult intravenous access, compared to the traditional clinical method" Bittencourt et al (2025).

IVTEAM

Safe injection practices in healthcare

"This position paper provides healthcare professionals (HCP) updated guidance with corresponding evidence and rationale to support safe injection, infusion, medication vial, and point-of-care testing practices in healthcare settings” Ormsby et al (2025).

IVTEAM

Accudrip gravity-based automatic infusion system – Full Text

"The gravity-based automatic infusion system showed high accuracy consistent with the theoretical rate of administration even under multiple infusion conditions of cancer patients with chemoport. This system (Accudrip) will greatly contribute to accurate drug administration and minimization of adverse events in real-world hospital settings" Park et al (2025).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video